We are excited to announce the launch of the Abundance and Growth Fund, which will spend at least $120 million over the next three years to accelerate economic growth and boost scientific and technological progress while lowering the cost of living.
We’re grateful for support from Good Ventures, which has committed $60M, and from the other private individuals who matched them. We’re also grateful for a contribution from Patrick Collison, who helped launch the Progress Studies movement.
We launched the fund because:
- Economic growth has transformed global living standards, and further growth could deliver vast improvements to health and well-being.
- Innovation is a key input to growth; economists and our own researchers estimate that R&D and scientific research have very high social returns.
- We have strong evidence that it’s possible to boost growth and innovation by removing existing constraints; there are many positive examples to point to where alternative systems have enabled faster progress.
- We thought the timing was right. (See below.)
We’ve long been one of the most active philanthropic funders in the pro-abundance and pro-growth movements, particularly in land use reform and innovation policy. We chose this moment to double down because:
- We feel encouraged by the recent rise of the Abundance and Progress Studies movements, which advocate for economic growth and material progress.
- We’ve seen cross-partisan interest in areas like zoning reform, energy permitting, and science policy.
- We learned a lot from launching the Lead Exposure Action Fund, which helped us quickly establish a similar pooled fund for abundance and growth.
See our blog post for more detail on all of these points.
With the launch of the Fund, we’re also launching a search for a program leader to manage it on a permanent basis. They will have significant autonomy in shaping the Fund’s direction and strategy. The application deadline is 3/31. We encourage you to check out the job description and apply yourself, or recommend someone who you think would be a strong candidate.
Thanks Nick.
On the housing piece: we have a long internal report on the valuation question that we didn't think was particularly relevant to external folks so we haven't published it, but will see about doing so later this year. Fn 7 and the text around it of this grant writeup explain the basic math of a previous version of that valuation calc, though our recent version is a lot more complex.
If you're asking about the bar math, the general logic is explained here and the move to a 2,100x bar is mentioned here.
On R&D, the 70x number comes from Matt Clancy's report (and I think we may have made some modest internal revisions but I don't think they change the bottom line much). You're right that that implies we need ~30x leverage to clear our bar. We sometimes think that is possible directly through strategic project selection - e.g., we fund direct R&D on neglected and important global health problems, and sometimes (in the case of this portfolio) through policy/advocacy. I agree 30x leverage presents a high bar and I think it's totally reasonable to be skeptical about whether we can clear it, but we think we sometimes can.